Department of Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Department of Biomedical Informatics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Oncoimmunology. 2023 Mar 25;12(1):2192098. doi: 10.1080/2162402X.2023.2192098. eCollection 2023.
Peripheral glia, specifically the Schwann cells (SCs), have been implicated in the formation of the tumor microenvironment (TME) and in cancer progression. However, and analyses of how cancers reprogram SC functions in different organs of tumor-bearing mice are lacking. We generated Plp1-CreERT/tdTomato mice which harbor fluorescently labeled myelinated and non-myelin forming SCs. We show that this model enables the isolation of the SCs with high purity from the skin and multiple other organs. We used this model to study phenotypic and functional reprogramming of the SCs in the skin adjacent to melanoma tumors. Transcriptomic analyses of the peritumoral skin SCs versus skin SCs from tumor-free mice revealed that the former existed in a repair-like state typically activated during nerve and tissue injury. Peritumoral skin SCs also downregulated pro-inflammatory genes and pathways related to protective anti-tumor responses. and functional assays confirmed immunosuppressive activities of the peritumoral skin SCs. Specifically, melanoma-reprogrammed SCs upregulated 12/15-lipoxygenase (12/15-LOX) and cyclooxygenase (COX)-2, and increased production of anti-inflammatory polyunsaturated fatty acid (PUFA) metabolites prostaglandin E2 (PGE2) and lipoxins A4/B4. Inhibition of 12/15-LOX or COX2 in SCs, or EP4 receptor on lymphocytes reversed SC-dependent suppression of anti-tumor T-cell activation. Therefore, SCs within the skin adjacent to melanoma tumors demonstrate functional switching to repair-like immunosuppressive cells with dysregulated lipid oxidation. Our study suggests the involvement of the melanoma-associated repair-like peritumoral SCs in the modulation of locoregional and systemic anti-tumor immune responses.
周围神经胶质细胞,特别是施万细胞 (SCs),已被牵涉到肿瘤微环境 (TME) 的形成和癌症进展中。然而,缺乏关于癌症如何在荷瘤小鼠的不同器官中重新编程 SC 功能的 和 分析。我们生成了 Plp1-CreERT/tdTomato 小鼠,其携带荧光标记的有髓鞘和无髓鞘形成的 SC。我们表明,该模型能够从皮肤和多个其他器官中分离出具有高纯度的 SC。我们使用该模型研究了黑色素瘤肿瘤附近皮肤 SC 的表型和功能重新编程。与无肿瘤小鼠皮肤 SC 相比,肿瘤周围皮肤 SC 的转录组分析表明,前者存在于修复样状态,通常在神经和组织损伤时被激活。肿瘤周围皮肤 SC 还下调了与保护性抗肿瘤反应相关的促炎基因和途径。 和 功能测定证实了肿瘤周围皮肤 SC 的免疫抑制活性。具体而言,黑色素瘤重编程的 SC 上调了 12/15-脂氧合酶 (12/15-LOX) 和环氧化酶 (COX)-2,并增加了抗炎多不饱和脂肪酸 (PUFA) 代谢物前列腺素 E2 (PGE2) 和脂氧素 A4/B4 的产生。在 SC 中抑制 12/15-LOX 或 COX2,或淋巴细胞上的 EP4 受体,可逆转 SC 依赖性抑制抗肿瘤 T 细胞激活。因此,黑色素瘤肿瘤附近皮肤中的 SC 表现出功能转换为具有失调脂质氧化的修复样免疫抑制细胞。我们的研究表明,黑色素瘤相关的修复样肿瘤周围 SC 参与了局部和全身抗肿瘤免疫反应的调节。